Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Soy Isoflavones For Inner City Infants At Risk For Asthma (SIRA) Study — Stella

Home/Wheezing/Soy Isoflavones For Inner City Infants At Risk For Asthma (SIRA) Study

View on ClinicalTrials.gov

Recruiting

Back to Wheezing trials

Soy Isoflavones For Inner City Infants At Risk For Asthma (SIRA) Study

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(2 sites)

United States

Ann and Robert H Lurie Childrens Hospital of Chicago, Chicago, Illinois

Northwestern University Feinberg School of Medicine, Chicago, Illinois

Key details

Phase

Safety & dosing

Sponsor

Rajesh Kumar

Collaborators

Northwestern University, University of South Florida

Enrollment target

~65 participants

Started

September 2024

Primary completion

March 2028

Age range

2 Months – 12 Months

Last updated November 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.